Exploration of different immunogenomic TMEs in gastric cancer based on HER2 and PD-L1 expression.
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.16_suppl.e16073
Abstract: e16073 Background: Recent results from the KEYNOTE-811 study showed that first-line pembrolizumab was superior to placebo with respect to progression-free survival (PFS) in combination with trastuzumab and chemotherapy in patients with HER2 positive metastatic gastric… read more here.
Keywords: samples cps; positive group; group; her2 positive ... See more keywords